A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants

Clinical trial NCT04898101 · COMPLETED

Trial details

NCT number: NCT04898101
Sponsor: Acerta Pharma BV
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-03-03
Primary completion: 2016-04-13
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.